|
1
|
Torre LA, Trabert B, DeSantis CE, Miller
KD, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A and Siegel
RL: Ovarian cancer statistics, 2018. Ca Cancer J Clin. 68:284–296.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cortez AJ, Tudrej P, Kujawa KA and
Lisowska KM: Advances in ovarian cancer therapy. Cancer Chemother
Pharmacol. 81:17–38. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma DD, Yuan LL and Lin L: LncRNA HOTAIR
contributes to the tumorigenesis of nasopharyngeal carcinoma via
up-regulating FASN. Eur Rev Med Pharmacol Sci. 21:5143–5152.
2017.PubMed/NCBI
|
|
4
|
Nie GH, Li Z, Duan HF, Luo L, Hu HY, Yang
WQ, Nie LP, Zhu RF, Chen XF and Zhang W: lncRNA C22orf32-1
contributes to the tumorigenesis of nasopharyngeal carcinoma. Oncol
Lett. 13:4487–4492. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiu JJ, Lin YY, Ding JX, Feng WW, Jin HY
and Hua KQ: Long non-coding RNA ANRIL predicts poor prognosis and
promotes invasion/metastasis in serous ovarian cancer. Int J Oncol.
46:2497–2505. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Richards EJ, Permuth-Wey J, Li Y, Chen YA,
Coppola D, Reid BM, Lin HY, Teer JK, Berchuck A, Birrer MJ, et al:
A functional variant in HOXA11-AS, a novel long non-coding RNA,
inhibits the oncogenic phenotype of epithelial ovarian cancer.
Oncotarget. 6:34745–34757. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhatlekar S, Fields JZ and Boman BM: HOX
genes and their role in the development of human cancers. J Mol Med
(Berl). 92:811–823. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang KC, Yang YW, Liu B, Sanyal A,
Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta
RA, et al: A long noncoding RNA maintains active chromatin to
coordinate homeotic gene expression. Nature. 472:120–124. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu ZQ, Chen CH, Zhou QB, Wang YX, Zhao Y,
Zhao X, Li W, Zheng S, Ye H, Wang L, et al: LncRNA HOTTIP modulates
cancer stem cell properties in human pancreatic cancer by
regulating HOXA9. Cancer Lett. 410:68–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Han H, Li Y, Zhang Q, Mo K and
Chen S: Upregulation of long noncoding RNA HOTTIP promotes
metastasis of esophageal squamous cell carcinoma via induction of
EMT. Oncotarget. 7:84480–84485. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zou T, Wang PL, Gao Y and Liang WT: Long
noncoding RNA HOTTIP is a significant indicator of ovarian cancer
prognosis and enhances cell proliferation and invasion. Cancer
Biomark. 25:133–139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu X, Tian J and Li QY: Downregulation of
HOTTIP regulates insulin secretion and cell cycle in islet β cells
via inhibiting MEK/ERK pathway. Eur Rev Med Pharmacol Sci.
22:4962–4968. 2018.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McCubrey JA, Steelman LS, Chappell WH,
Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M,
Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth,
malignant transformation and drug resistance. Biochim Biophys Acta.
1773:1263–1284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang S, Yan Y, Cheng Z, Hu Y and Liu T:
Sotetsuflavone suppresses invasion and metastasis in non-small-cell
lung cancer A549 cells by reversing EMT via the TNF-α/NF-κB and
PI3K/AKT signaling pathway. Cell Death Discov. 4:262018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang YB and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nikpayam E, Tasharrofi B, Sarrafzadeh S
and Ghafouri-Fard S: The role of long non-coding RNAs in ovarian
cancer. Iran Biomed J. 21:3–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu Y, Biglia N, Wang Z, Shen Y, Risch HA,
Lu L, Canuto EM, Jia W, Katsaros D and Yu H: Long non-coding RNAs,
ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer.
Gynecol Oncol. 143:642–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vafaee F, Colvin EK, Mok SC, Howell VM and
Samimi G: Functional prediction of long non-coding RNAs in ovarian
cancer-associated fibroblasts indicate a potential role in
metastasis. Sci Rep. 7:103742017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan Q, Liu Y, Fan Y, Liu Z, Wang X, Jia
M, Geng Z, Zhang J and Lu X: LncRNA HOTTIP promotes papillary
thyroid carcinoma cell proliferation, invasion and migration by
regulating miR-637. Int J Biochem Cell Biol. 98:1–9. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu T, Yu T, Hu H and He K: Knockdown of
the long non-coding RNA HOTTIP inhibits colorectal cancer cell
proliferation and migration and induces apoptosis by targeting
SGK1. Biomed Pharmacother. 98:286–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen M, Li M and Liu J: Long noncoding RNA
HOTTIP promotes nasopharyngeal cancer cell proliferation,
migration, and invasion by inhibiting miR-4301. Med Sci Monit.
25:778–785. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao W, Wu XL, Li DZ and Liu HD: HOTTIP
participates in mammary cancer by promoting cell proliferation via
PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 22:4181–4187.
2018.PubMed/NCBI
|
|
24
|
Guan Q, Zhang Q, Zhang C, Liu Q and Ren
QL: HOTTIP regulates progression of endometrial cancer via
activating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci.
22:3727–3733. 2018.PubMed/NCBI
|
|
25
|
Su Y, Lu J, Chen X, Liang C, Luo P, Qin C
and Zhang J: Long non-coding RNA HOTTIP affects renal cell
carcinoma progression by regulating autophagy via the
PI3K/Akt/Atg13 signaling pathway. J Cancer Res Clin Oncol.
145:573–588. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao B, Chen R, Lin F, Mai A, Chen J, Li
H, Xu Z and Dong S: Long noncoding RNA HOTTIP promotes endothelial
cell proliferation and migration via activation of the
Wnt/β-catenin pathway. J Cell Biochem. 119:2797–2805. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo L, Bai Y, Ji S and Ma H: MicroRNA-98
suppresses cell growth and invasion of retinoblastoma via targeting
the IGF1R/k-Ras/Raf/MEK/ERK signaling pathway. Int J Oncol.
54:807–820. 2019.PubMed/NCBI
|
|
28
|
Yu ZT, Ye SQ, Hu GY, Lv M, Tu Z, Zhou K
and Li QB: The RAF-MEK-ERK pathway: Targeting ERK to overcome
obstacles of effective cancer therapy. Future Med Chem. 7:269–289.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang HZ, Jiang HJ, Zhang HX, Liu JC, Hu X
and Chen L: Ribophorin II potentiates P-glycoprotein- and
ABCG2-mediated multidrug resistance via activating ERK pathway in
gastric cancer. Int J Biol Macromol. 128:574–582. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu FF, Pang GL and Zhao GQ: ANRIL acts as
onco-lncRNA by regulation of microRNA-24/c-Myc, MEK/ERK and
Wnt/β-catenin pathway in retinoblastoma. Int J Biol Macromol.
128:583–592. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Guo XJ, Xie CC and Jiang JX: KIF15
promotes pancreatic cancer proliferation via the MEK-ERK signalling
pathway. Br J Cancer. 117:245–255. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hua F, Li CH, Chen XG and Liu XP: Daidzein
exerts anticancer activity towards SKOV3 human ovarian cancer cells
by inducing apoptosis and cell cycle arrest, and inhibiting the
Raf/MEK/ERK cascade. Int J Mol Med. 41:3485–3492. 2018.PubMed/NCBI
|
|
33
|
Durruthy-Durruthy J, Sebastiano V,
Wossidlo M, Cepeda D, Cui J, Grow EJ, Davila J, Mall M, Wong WH,
Wysocka J, et al: The primate-specific noncoding RNA HPAT5
regulates pluripotency during human preimplantation development and
nuclear reprogramming. Nat Genet. 48:44–52. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing MiRNA-LncRNA interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jafarnejad SM, Chapat C, Matta-Camacho E,
Gelbart IA, Hesketh GG, Arguello M, Garzia A, Kim SH, Attig J,
Shapiro M, et al: Translational control of ERK signaling through
miRNA/4EHP-directed silencing. Elife. 7:e350342018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou K, Luo X, Wang Y, Cao D and Sun G:
MicroRNA-30a suppresses tumor progression by blocking
Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
Biomed Pharmacother. 93:1025–1032. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
